| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/16/2005 | CN1579421A Freeze-dried powder of pig's lung surface matter, its preparation method and use |
| 02/16/2005 | CN1579418A Preparation pixuanjing for treating psoriasis and its preparation method |
| 02/16/2005 | CN1579416A Medicinal composition for treating liver disease, its prepration method and use |
| 02/16/2005 | CN1579412A Cytidine triphosphate disodium chloride injecta and its preparation process |
| 02/16/2005 | CN1579407A Nasal administration preparation for anti-AIDS-virus brain infection and use thereof |
| 02/16/2005 | CN1579406A Drip pill agent containing adefovir divoxil and its preparing method |
| 02/16/2005 | CN1579405A External medicine for killing and inhibiting fungus |
| 02/16/2005 | CN1579404A Novel preparation of glycyrrhizin |
| 02/16/2005 | CN1579402A Medicinal composition for treating bacterial conjunctivitis and keratitis and preparation and preparation method |
| 02/16/2005 | CN1579400A Compound cycle-free guanosine eye drops |
| 02/16/2005 | CN1579397A Total matrine and use of its preparation in zoopharmacy |
| 02/16/2005 | CN1579395A Diflucan freeze-dried powder injecta and preparation method thereof |
| 02/16/2005 | CN1579393A Transparaent and disappearing external medicine preparation containing benzotolazo |
| 02/16/2005 | CN1579386A Armillarisin A solution preparation and its preparing method |
| 02/16/2005 | CN1579385A New Preparation of Gantaile |
| 02/16/2005 | CN1579377A Use of Rhizoma-Curcumae-Longae element in preparing medicine for treating lung disease |
| 02/16/2005 | CN1579375A Garlic element fat emulsion and its preparation process |
| 02/16/2005 | CN1579189A Chewing gum coutaining licorice-root extract |
| 02/16/2005 | CN1189478C Cyclic compound |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189471C Phosphonocephem compound |
| 02/16/2005 | CN1189469C 3-(heteroaryl acetamido)-2-oxo-azeridine-1-sulfonic acid derivatives as anti-bacterial agents |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189208C Chinese medicine composition for curing child common cold fever |
| 02/16/2005 | CN1189206C Medicine for curing leuconychia and hand-foot ringworm and preoaring method thereof |
| 02/16/2005 | CN1189203C Chinese medicaine for treating hepatocirrhosis, hepatitis and liver cancer |
| 02/16/2005 | CN1189197C Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promting blood circulation and promoting tissue regeneration |
| 02/16/2005 | CN1189196C Compound sarcandra glabra injection |
| 02/16/2005 | CN1189183C Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases |
| 02/16/2005 | CN1189178C Medicine use of cooperation substance of zinc glycoside of baikal skullcap root |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/16/2005 | CN1189161C Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral adminisration thereof |
| 02/15/2005 | US6855724 Tropane derivatives useful in therapy |
| 02/15/2005 | US6855712 Combination of benzoquinazoline antifolates and protecting agents |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855492 Entrained antigen; oil in water emulsion; vaccine |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855315 Kits for detecting swine infertility and respiratory syndrome (SIRS) virus |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2421026C Viral inhibition by n-docosanol |
| 02/15/2005 | CA2141056C Treatment of dentoalveolar infections with taurolidine and/or taurultam |
| 02/14/2005 | WO2005024025A1 Polyene polyketides and methods of production |
| 02/10/2005 | WO2005012528A1 A method of preparing epitopes chimeric gene vaccine |
| 02/10/2005 | WO2005012503A1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 02/10/2005 | WO2005012360A2 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | WO2005012358A2 Use of adcc-optimized antibodies for treating weak patients |
| 02/10/2005 | WO2005012337A2 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012302A1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012276A2 Intermediate products of the synthesis of fluorized inhibitors of aspartic proteases |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012259A1 Method of inhibiting production of osteopontin |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012210A2 Antimicrobial active preparations containing terpene derivatives |
| 02/10/2005 | WO2005011730A1 Microsome vaccine |
| 02/10/2005 | WO2005011707A1 A doxycycline metal complex in a solid dosage form |
| 02/10/2005 | WO2005011702A1 Process for preparing particles containing an antiviral |
| 02/10/2005 | WO2005011699A1 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| 02/10/2005 | WO2005011679A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 02/10/2005 | WO2005011649A2 Methods of treating severe acute respiratory syndrome virus infections |
| 02/10/2005 | WO2005000345A3 Immunization method against neisseria meningitidis serogroups a and c |
| 02/10/2005 | WO2004113357A3 Nucleoside analog inhibitors of reverse transcriptase |
| 02/10/2005 | WO2004110979A3 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 02/10/2005 | WO2004110480A3 Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines |
| 02/10/2005 | WO2004103401A3 Avian combination-vaccine against e.coli and salmonella |
| 02/10/2005 | WO2004096823A3 Novel ketolide derivatives |
| 02/10/2005 | WO2004094462A3 Methods of peptide preparation |
| 02/10/2005 | WO2004093903A3 Methods and compositions for immunomodulation using cd1 antigens |
| 02/10/2005 | WO2004060860A3 Method for inhibiting the replication of herpes viruses |
| 02/10/2005 | WO2004035032A3 Pharmaceutical formulations of camptothecine derivatives |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | US20050033066 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033051 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection using modified nucleotides; viricides |
| 02/10/2005 | US20050033025 Human papilloma viral proteins fragments for use in generating immunoglobullins for treatment and prevention infection; immunotherapeutics and diagnostice; viricides |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050032911 Alcoholism; gastrointestinal disorders, Crohn's disease, antiulcer agents induced by alcoholism |
| 02/10/2005 | US20050032895 Medicament for the treatment of viral skin and tumour diseases |
| 02/10/2005 | US20050032883 Novel substance fki-1083 and process for producing the same |
| 02/10/2005 | US20050032861 Antibiotic (vancomycin) resistant Grampositive and Gramnegative bacteria; cycloadditon, reduction, coupling, salt formation, deprotecting, amination, oxidation |
| 02/10/2005 | US20050032855 Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032830 Ether substituted imidazopyridines |
| 02/10/2005 | US20050032826 Medical devices containing rapamycin analogs |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032823 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 02/10/2005 | US20050032822 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032793 For example, 1,1-dimethylethyl [2-[[2-(diethylamino)-2-oxo-1S-(phenylmethyl)ethyl]amino]-5-methyl-4-oxo-4H-3,1-benzoxazin-6-yl]carbamate; for treating herpes-related disorders |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032786 1, 3-benzothiazinone derivatives and use thereof |
| 02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
| 02/10/2005 | US20050032775 Aztreonam L-lysine and methods for the preparation thereof |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032771 Process for the preparation of cefixime via alkyl-or aryl-sulfonates |